IGIC CEO Form 3 details 37,840 International General common shares

Rhea-AI Filing Summary

International General Insurance Holdings Ltd. executive Loucaides Andreas Costas, CEO of IGI UK, reports beneficial ownership of 37,840 common shares. This includes 37,500 restricted shares granted under the 2020 Omnibus Incentive Plan and 340 shares purchased through the U.K. Employee Stock Purchase Plan.

The restricted shares vest in tranches on January 2, 2027 (21,000 shares), January 2, 2028 (11,000 shares), and January 2, 2029 (5,500 shares). The 340 ESPP shares vest gradually, with portions scheduled to vest between April 10, 2026 and January 7, 2027.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Loucaides Andreas Costas

Role CEO, IGI UK

Type	Security	Shares	Price	Value
holding	Common Shares	--	--	--

Holdings After Transaction: Common Shares — 37,840 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Loucaides Andreas Costas

(Last) (First) (Middle)

FORUM HOUSE, 15-18 LIME STREET

(Street)

LONDON EC3M 7AN

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
International General Insurance Holdings Ltd. [ IGIC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, IGI UK

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	37,840(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 37,500 restricted shares awarded to the reporting person under the International General Insurance Holdings Ltd. 2020 Omnibus Incentive Plan, and 340 common shares purchased by the reporting person pursuant to the U.K. Employee Stock Purchase Plan ("ESPP Shares"). Of the 37,500 restricted shares, 21,000 will vest on January 2, 2027, 11,000 will vest on January 2, 2028, and 5,500 will vest on January 2, 2029. Of the 340 ESPP Shares, 239 of the ESPP Shares have vested, 26 will vest on April 10, 2026, 25 will vest on July 3, 2026, 26 will vest on October 6, 2026, and 24 will vest on January 7, 2027.

	/s/ Andreas Costas Loucaides	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the IGIC Form 3 filed by Loucaides Andreas Costas show?

The Form 3 shows Loucaides Andreas Costas, CEO of IGI UK, beneficially owns 37,840 IGIC common shares. These consist mainly of restricted stock grants and shares bought under the U.K. Employee Stock Purchase Plan, with future vesting dates specified.

How many International General Insurance (IGIC) shares does the IGI UK CEO own?

The IGI UK CEO reports beneficial ownership of 37,840 IGIC common shares. This total includes 37,500 restricted shares granted under the 2020 Omnibus Incentive Plan and 340 shares purchased through the U.K. Employee Stock Purchase Plan.

What are the vesting dates for the IGIC restricted shares reported on the Form 3?

The 37,500 restricted IGIC shares vest in three tranches: 21,000 shares on January 2, 2027, 11,000 shares on January 2, 2028, and 5,500 shares on January 2, 2029. These dates define when the executive’s ownership becomes fully unrestricted.

How are the IGIC Employee Stock Purchase Plan shares structured for the IGI UK CEO?

The CEO holds 340 IGIC shares from the U.K. Employee Stock Purchase Plan. Of these, 239 have vested, while the remainder vest on April 10, 2026, July 3, 2026, October 6, 2026, and January 7, 2027, reflecting a staged vesting schedule.

Is the IGIC Form 3 a record of a new insider trade or just holdings?

The IGIC Form 3 functions as an initial statement of holdings for the IGI UK CEO, not a buy or sell transaction report. It details his existing ownership in common shares, restricted stock, and ESPP shares, along with their future vesting timelines.